ICU vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 15, 2026

ICU

57.6
AI Score
VS
ICU Wins

IMMX

43.0
AI Score

Investment Advisor Scores

ICU

58score
Recommendation
HOLD

IMMX

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU IMMX Winner
Revenue 1.23M 20.00M IMMX
Net Income -12.15M -21.64M ICU
Net Margin -984.6% -108.2% IMMX
Operating Income -12.18M -23.26M ICU
ROE -116.6% -9.5% IMMX
ROA -85.8% -9.1% IMMX
Total Assets 14.16M 239.11M IMMX
Cash 11.98M 225.49M IMMX
Current Ratio 3.63 25.13 IMMX

Relative Price Performance (Last 90 Days)

ICU 1M: +62.8% · 3M: -1.5% IMMX 1M: -30.7% · 3M: -7.4%

Current Technical Phase

ICU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 77.5 · Price: $4.69

IMMX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.4 · Price: $9.68

Fundamentals Snapshot

Metric ICU IMMX
Market Cap — —
Forward P/E -2.0 -11.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.8% 0.0%
Gross Margin 0.9% —
Operating Margin -6.2% 0.0%
EPS -1.89 -0.88
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.